XML 48 R61.htm IDEA: XBRL DOCUMENT v2.4.1.9
Acquisitions and License Agreements (Schedule of Pro Forma Information) (Details) (Questcor and Cadence Pharmaceuticals, USD $)
In Millions, except Per Share data, unless otherwise specified
12 Months Ended
Sep. 26, 2014
Sep. 27, 2013
Questcor and Cadence Pharmaceuticals
   
Business Acquisition [Line Items]    
Net sales, pro forma $ 3,487.1us-gaap_BusinessAcquisitionsProFormaRevenue
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorAndCadencePharmaceuticalsMember
$ 3,015.5us-gaap_BusinessAcquisitionsProFormaRevenue
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorAndCadencePharmaceuticalsMember
Net income (loss), pro forma $ (326.8)us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorAndCadencePharmaceuticalsMember
$ (61.5)us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorAndCadencePharmaceuticalsMember
Basic earnings (loss) per share, pro forma (in usd per share) $ (2.84)us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorAndCadencePharmaceuticalsMember
$ (0.54)us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorAndCadencePharmaceuticalsMember
Diluted earnings (loss) per share, pro forma (in usd per share) $ (2.84)us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorAndCadencePharmaceuticalsMember
$ (0.54)us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorAndCadencePharmaceuticalsMember